Search bioRxiv⌕ Search

Biology subjects

Deeb, A.

Publications and source records attributed to Deeb, A..

2 recordsLinked to original sources

Longitudinal persistence of EEG brain fingerprints:phase and complex coherency geometry across sessions andfunctional states

Sensor-level EEG coherency can distinguish individuals, although its phase and magnitude patterns may reflect neural activity, source mixing, and recording geometry. We evaluated two geometric representations of complex coherency - unit phasors and full complex coherency - alongside triangle holonomies and magnitude-only descriptors. Using direct enrollment-probe matching without a trained identity classifier, we analyzed three independent longitudinal cohorts: RestCog (N = 60; approximately one month), L-FAME (N = 44; six weeks), and Dortmund (N = 206; approximately five years). In eyes-closed rest-to-rest matching, alpha phasors identified 81.67% of participants in RestCog (AUC 0.9473) and 79.55% in L-FAME (AUC 0.9735); full complex coherency identified 78.33% and 84.09%, respectively. After five years in Dortmund, fixed row-standardized alpha-beta fusion yielded 77.67% rank-1 identification (AUC 0.9744) for phasors and 70.39% (AUC 0.9527) for full coherency. Changes in functional state exposed different strengths: full coherency preserved higher rank-1 accuracy in some monthly RestCog rest-to-task comparisons, whereas alpha phasors retained higher verification AUC. Switching between eyes-closed and eyes-open recordings in Dortmund substantially weakened identification with both representations. Triangle holonomies also retained individual information across visits. An exact factorization of complex cosine shows how magnitude-pattern alignment and magnitude-weighted phase agreement contribute to full-coherency matching. Together, the results establish longitudinally discriminative structure in measured scalp EEG coherency over weeks to years, while distinguishing persistence across visits from robustness to changes in recording state.

neuroscience↗

Availability of Medications Used for Puberty Induction and Maintenance in Adolescents with Hypogonadism in the Arab Region A Deeb1*, H AlSaffar2, RT Hamza3, AM Habeb4

PurposeInducing puberty in hypogonadal patients enables achieving normal final adult height, healthy bone mass accrual and improves fertility potential. Reliable availability and access to medicines remain a challenge around the world, particularly in low income countries. We aim to study the availability/access to medications used for inducing and maintaining puberty in centers within the Arab region. Patients and MethodsA cross-sectional survey was conducted using a link to an online questionnaire which was emailed to paediatric endocrinologists in the Arab region. The questionnaire consisted of three questions related to availability of various forms of sex hormones. Results99 physicians from 16 countries participated in the study. The commonest available form of estrogen was conjugated estrogen (29% of centers) followed by ethinylestradiol in 26%. Depot estradiol was available in 11centers while topical estrogen preparations of gel and patches were available in 6 and 10 centers respectively. Medroxy progesterone was available in 26% of the centers followed by noresthisterone (24%). The combined forms of oral and transdermal patches of estrogen/progestorne were available in 35 and 9% of centers. Intramuscular testosterone (Sustanon) was the most commonly available preparation of testosterone followed by the depot injection (Nebido), oral testosterone and testosterone gel and cream. ConclusionsWe report the first availability data of medications used for puberty induction and maintenance in paediatric hypogonadism in the Arab region. Recommended preparations for this purpose are not widely available. Creating essential list of medications used in paediatric endocrinology disorders might improve availability, access and consequently practice.

pharmacology and toxicology↗